+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Glucagon-Like Peptide 1 Agonists Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Glucagon-Like Peptide 1 Agonists Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Diabetes Care Drugs Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Diabetes Care Drugs Market - Forecasts from 2022 to 2027

  • Report
  • October 2022
  • 138 Pages
  • Global
From
Japan Diabetes Drugs And Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Thumbnail Image

Japan Diabetes Drugs And Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • April 2025
  • 70 Pages
  • Japan
From
Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 189 Pages
  • Global
From
WEGOVY (Semaglutide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

WEGOVY (Semaglutide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Type 2 Diabetes Market Report and Forecast 2024-2032 - Product Thumbnail Image

Type 2 Diabetes Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 160 Pages
  • Global
From
Prediabetes Treatment Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Prediabetes Treatment Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region - Product Thumbnail Image

Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Endocrinology Drugs Market by Therapy Area, Distribution Channel, and By Region - Product Thumbnail Image

Endocrinology Drugs Market by Therapy Area, Distribution Channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Anti-diabetic Drugs Market - Product Thumbnail Image

Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Diabetes Care Drugs Market Analysis & Forecast to 2023-2033: Market By Drugs; By Type; By Rote of Administration; By End-user; and By Region - Product Thumbnail Image

Diabetes Care Drugs Market Analysis & Forecast to 2023-2033: Market By Drugs; By Type; By Rote of Administration; By End-user; and By Region

  • Report
  • August 2023
  • 145 Pages
  • Global
From
Thyroid Gland Disorders Treatment Market Analysis & Forecast to 2023-2033: Market By Indication; By Route of Administration; By Distribution Channel; and by Region - Product Thumbnail Image

Thyroid Gland Disorders Treatment Market Analysis & Forecast to 2023-2033: Market By Indication; By Route of Administration; By Distribution Channel; and by Region

  • Report
  • July 2023
  • 145 Pages
  • Global
From
Asia-Pacific Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

Asia-Pacific Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 205 Pages
  • Asia Pacific
From
South America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

South America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 177 Pages
From
North America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

North America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 174 Pages
  • North America
From
Middle East & Africa Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

Middle East & Africa Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 181 Pages
  • Africa, Middle East
From
Europe Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

Europe Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 202 Pages
  • Europe
From
Insulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Geography - Product Thumbnail Image

Insulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Geography

  • Report
  • July 2022
  • 255 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more